Who Is a Good Candidate for Ketamine Therapy?

Determining Candidacy

Ketamine therapy is not appropriate for everyone, and determining whether a patient is a good candidate requires careful medical and psychiatric evaluation. While the rapid antidepressant effects of ketamine have generated significant public interest, the decision to pursue ketamine treatment should be made collaboratively between the patient and a qualified healthcare provider, based on a thorough assessment of the individual's clinical situation.

Conditions That May Respond to Ketamine

Treatment-Resistant Depression (TRD)

The strongest evidence for ketamine's psychiatric use is in treatment-resistant depression — defined as major depressive disorder that has not responded adequately to at least two different antidepressant medications given at appropriate doses for sufficient duration. TRD is the most well-studied indication and the condition for which the FDA approved esketamine (Spravato).

Patients who may be particularly good candidates include those who:

• Have tried multiple antidepressants without adequate relief
• Experience severe functional impairment due to depression
• Have depression with prominent anhedonia (inability to feel pleasure)
• Need rapid symptom relief due to the severity of their condition

Depression With Suicidal Ideation

Ketamine has demonstrated a unique ability to rapidly reduce suicidal ideation, often within hours. For patients experiencing active suicidal thoughts, ketamine may be considered as an acute intervention, particularly when rapid stabilization is needed while longer-term treatments take effect.

Post-Traumatic Stress Disorder (PTSD)

Growing evidence supports ketamine's use for PTSD, particularly in patients who have not responded to established treatments such as trauma-focused psychotherapy and FDA-approved medications (sertraline, paroxetine). Veterans and first responders with treatment-resistant PTSD are an area of active clinical and research interest.

Chronic Pain Conditions

Ketamine may benefit patients with certain chronic pain conditions, especially those involving neuropathic pain or central sensitization, such as:

• Complex Regional Pain Syndrome (CRPS)
• Neuropathic pain syndromes
• Fibromyalgia
• Refractory migraine

Other Conditions Under Investigation

Preliminary research has explored ketamine for several other conditions, though the evidence is less established:

• Obsessive-compulsive disorder (OCD)
• Bipolar depression (depressive episodes within bipolar disorder)
• Social anxiety disorder
• Substance use disorders (alcohol use disorder in particular)
• Eating disorders

Screening Criteria

A thorough screening process is essential before initiating ketamine therapy. Standard screening components include:

Medical Assessment

• Cardiovascular evaluation — Blood pressure, heart rate, and cardiac history are reviewed. Uncontrolled hypertension is a primary medical contraindication.
• Liver function — Since ketamine is metabolized by the liver, significant hepatic impairment may affect dosing and safety.
• Urological history — Chronic, high-dose ketamine use has been associated with bladder damage. Patients with existing urinary tract problems warrant careful evaluation.
• Pregnancy status — Ketamine is generally not recommended during pregnancy due to limited safety data.
• Current medications — Potential interactions are reviewed, including with MAO inhibitors, benzodiazepines, and other sedating medications. For details on drug interactions, see our ketamine pharmacology guide.

Psychiatric Assessment

• Diagnostic clarity — A confirmed psychiatric diagnosis supported by a comprehensive evaluation
• Treatment history — Documentation of previous medication trials and psychotherapy
• Psychotic symptoms — Active psychosis or a history of psychotic disorders (such as schizophrenia) is generally a contraindication
• Substance use history — A history of ketamine or PCP abuse is typically a contraindication. Other substance use disorders require careful consideration.
• Mania risk — Patients with bipolar disorder should be evaluated for the risk of ketamine-induced manic episodes, though this risk appears to be low

Contraindications

Certain conditions are generally considered contraindications to ketamine therapy:

Absolute Contraindications

• Known allergy or hypersensitivity to ketamine
• Active psychotic symptoms or poorly controlled psychotic disorder
• Uncontrolled hypertension
• Conditions associated with elevated intracranial pressure (e.g., intracranial mass lesion, hydrocephalus)

Relative Contraindications (Require Careful Evaluation)

• History of substance use disorder, particularly involving ketamine, PCP, or other dissociative drugs
• Unstable cardiovascular disease
• Severe liver disease
• Pregnancy or breastfeeding
• Active mania
• Untreated hyperthyroidism

The Evaluation Process

A typical evaluation process for ketamine therapy candidacy includes:

1. Initial consultation — A comprehensive interview covering psychiatric history, medical history, current symptoms, previous treatments, and treatment goals
2. Questionnaires — Standardized depression, anxiety, and PTSD rating scales to establish baseline symptom severity
3. Medical review — Review of vital signs, relevant laboratory results, and medication list
4. Risk assessment — Evaluation of suicide risk, substance use risk, and potential for adverse events
5. Informed consent — Detailed discussion of the benefits, risks, alternatives, and expectations of treatment
6. Treatment planning — Development of an individualized treatment plan including dosing, frequency, and integration with other therapies

Questions to Ask Your Provider

If you are considering ketamine therapy, useful questions to ask your provider include:

• What is your clinical experience with ketamine therapy?
• What monitoring is provided during and after treatment?
• What is the recommended treatment protocol for my condition?
• What are the expected costs, and is insurance accepted?
• How will ketamine therapy be integrated with my other treatments?
• What is the plan for maintenance treatment if I respond well?
• What side effects should I watch for between sessions?
• What happens if I do not respond to the initial series?

The Bottom Line

Ketamine therapy can be a powerful tool for the right patient, but careful selection is essential for both safety and efficacy. The best candidates are those who have a clear psychiatric or pain diagnosis, have not responded adequately to conventional treatments, do not have contraindications, and are willing to engage in a comprehensive treatment plan. A thorough evaluation by a qualified provider is the first and most important step. For general guidance, see this complete guide to ketamine therapy in determining whether ketamine therapy is appropriate for you.

References

• StatPearls: Ketamine — Clinical reference covering ketamine indications, contraindications, and patient screening criteria
• NIMH: Depression — National Institute of Mental Health overview of depression, including treatment-resistant depression
• MedlinePlus: Ketamine Injection — National Library of Medicine information on ketamine precautions and contraindications
• MedlinePlus: Esketamine Nasal Spray — Drug information on esketamine including patient eligibility criteria for Spravato treatment